BRPI0417491A - composção e métodos para modular a atividade do snc - Google Patents

composção e métodos para modular a atividade do snc

Info

Publication number
BRPI0417491A
BRPI0417491A BRPI0417491-7A BRPI0417491A BRPI0417491A BR PI0417491 A BRPI0417491 A BR PI0417491A BR PI0417491 A BRPI0417491 A BR PI0417491A BR PI0417491 A BRPI0417491 A BR PI0417491A
Authority
BR
Brazil
Prior art keywords
methods
compositions
present
composition
disorders
Prior art date
Application number
BRPI0417491-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Lee L Rubin
Original Assignee
Curis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curis Inc filed Critical Curis Inc
Publication of BRPI0417491A publication Critical patent/BRPI0417491A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
BRPI0417491-7A 2003-12-19 2004-12-15 composção e métodos para modular a atividade do snc BRPI0417491A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53120103P 2003-12-19 2003-12-19
PCT/US2004/042271 WO2005061002A2 (en) 2003-12-19 2004-12-15 Composition and methods for modulating cns activity

Publications (1)

Publication Number Publication Date
BRPI0417491A true BRPI0417491A (pt) 2007-05-22

Family

ID=34710209

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417491-7A BRPI0417491A (pt) 2003-12-19 2004-12-15 composção e métodos para modular a atividade do snc

Country Status (9)

Country Link
US (1) US20050203014A1 (enExample)
EP (1) EP1694353A2 (enExample)
JP (1) JP2007521333A (enExample)
CN (1) CN1917897A (enExample)
AU (1) AU2004305582A1 (enExample)
BR (1) BRPI0417491A (enExample)
CA (1) CA2547338A1 (enExample)
MX (1) MXPA06006659A (enExample)
WO (1) WO2005061002A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7632679B2 (en) * 2002-07-16 2009-12-15 The Trustees Of Columbia University In The City Of New York Systems and methods for screening for modulators of neural differentiation
US20040224302A1 (en) * 2002-07-16 2004-11-11 Thomas Jessel Systems and methods for screening for modulators of neural differentiation
US7390659B2 (en) 2002-07-16 2008-06-24 The Trustees Of Columbia University In The City Of New York Methods for inducing differentiation of embryonic stem cells and uses thereof
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
US20090246145A1 (en) * 2005-11-14 2009-10-01 Small Scott A Imaging Correlates of Neurogenesis With MRI
US9765297B2 (en) * 2007-04-13 2017-09-19 The Trustees Of Columbia University In The City Of New York Stem cell-based culture system for drug development
US8969081B2 (en) * 2008-12-10 2015-03-03 The Trustees Of Columbia University In The City Of New York Caudal motor neuron derived from embryonic stem cells under conditions essentially free of any retinoid
FR2966733B1 (fr) * 2010-10-29 2012-12-14 Centre Nat Rech Scient Nouvelles strategies therapeutiques impliquant la voie de signalisation hedgehog
CN104740633A (zh) * 2013-12-26 2015-07-01 中国科学院上海生命科学研究院 Shh信号通路特异性抑制剂的应用
JP6193176B2 (ja) * 2014-05-12 2017-09-06 ライオン株式会社 活力及び／又は集中力向上剤
CN111551729B (zh) * 2020-04-27 2021-02-09 浙江正熙生物技术股份有限公司 藻红蛋白免疫荧光探针制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789543A (en) * 1993-12-30 1998-08-04 President And Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins and uses related thereto
US6610656B1 (en) * 1993-12-30 2003-08-26 President And Fellows Of Harvard College Method of promoting chondrocyte differentiation with hedgehog related polypeptides
US6384192B1 (en) * 1993-12-30 2002-05-07 President & Fellows Of Harvard College Vertebrate embryonic pattern-inducing proteins
US6165747A (en) * 1993-12-30 2000-12-26 President & Fellows Of Harvard College Nucleic acids encoding hedgehog proteins
US6261786B1 (en) * 1993-12-30 2001-07-17 Imperial Cancer Res. Technology Screening assays for hedgehog agonists and antagonists
DE69534310T2 (de) * 1994-10-07 2006-04-27 The Board Of Trustees Of The Leland Stanford Junior University, Palo Alto Ptc gene und ihre verwendung
US6429354B1 (en) * 1994-10-07 2002-08-06 The Board Of Trustees Of The Leland Stanford Junior University Patched genes and uses related thereto
US6027882A (en) * 1994-10-07 2000-02-22 The Regents Of The University Of California Patched genes and their use for diagnostics
US7144997B2 (en) * 1997-07-24 2006-12-05 Curis, Inc. Vertebrate embryonic patterning-inducing proteins, compositions and uses related therto
US6897297B1 (en) * 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
JP2003524388A (ja) * 1998-12-03 2003-08-19 バイオジェン インコーポレイテッド 興奮毒性を含む疾患を治療するための方法及び組成物
EP1743903A2 (en) * 1998-12-03 2007-01-17 Curis, Inc. Methods and compositions for treating disorders involving excitotoxicity
US20030165897A1 (en) * 1999-12-21 2003-09-04 Burke Richard E. Dispatched polypeptides
US6683192B2 (en) * 2000-03-30 2004-01-27 Curis, Inc. Small organic molecule regulators of cell proliferation
US20030104995A1 (en) * 2000-04-28 2003-06-05 Reilly Jennifer Ott Neuroprotective methods and compositions
US6528518B2 (en) * 2000-12-21 2003-03-04 The Mclean Hospital Corporation Treatment of depression with kappa receptor antagonists
US20060078499A1 (en) * 2003-12-01 2006-04-13 Rene Hen Use of hedgehog agonist to treat depression

Also Published As

Publication number Publication date
JP2007521333A (ja) 2007-08-02
EP1694353A2 (en) 2006-08-30
WO2005061002A3 (en) 2005-09-29
US20050203014A1 (en) 2005-09-15
MXPA06006659A (es) 2006-08-31
WO2005061002A2 (en) 2005-07-07
AU2004305582A1 (en) 2005-07-07
CA2547338A1 (en) 2005-07-07
CN1917897A (zh) 2007-02-21

Similar Documents

Publication Publication Date Title
Park et al. Physical exercise during exposure to 40-Hz light flicker improves cognitive functions in the 3xTg mouse model of Alzheimer’s disease
Levy Migraine pain and nociceptor activation—where do we stand?
Boggio et al. Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depression
Su et al. Intermittent theta burst transcranial magnetic stimulation for methamphetamine addiction: a randomized clinical trial
Kreuzer et al. Mindfulness-and body-psychotherapy-based group treatment of chronic tinnitus: a randomized controlled pilot study
Rossi et al. Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo‐controlled study
Baydas et al. Learning and memory deficits in rats induced by chronic thinner exposure are reversed by melatonin
BR0313153A (pt) Derivado de quinuclidina, composição farmacêutica, uso de um derivado de quinuclidina, e, método de tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou uma condição de um corpo animal vivo
BRPI0417491A (pt) composção e métodos para modular a atividade do snc
Vachez et al. Subthalamic nucleus stimulation impairs motivation: implication for apathy in Parkinson's disease
Stockbridge et al. Reversing the ruin: rehabilitation, recovery, and restoration after stroke
Yildiz et al. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study
Holloway et al. Cerebellar modulation of mesolimbic dopamine transmission is functionally asymmetrical
Fastman et al. A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
de Azevedo et al. Treatment of tinnitus with acamprosate
Ikeda et al. Differential rostral projections of caudal brainstem neurons receiving trigeminal input after masseter inflammation
Cha et al. Astroglial changes in the zona incerta in response to motor cortex stimulation in a rat model of chronic neuropathy
Bhidayasiri et al. Treatment of dystonia
Al-Ayadhi et al. Effectiveness of Auditory Integration Therapy in Autism Spectrum Disorders--Prospective Study.
Gershon Chronic pain: hypothesized mechanism and rationale for treatment
Yu et al. Ultrasound‐guided stellate ganglion block for the treatment of migraine in elderly patients: A retrospective and observational study
Nguyen et al. Electroacupuncture prevents cocaine-induced conditioned place preference reinstatement and attenuates ΔFosB and GluR2 expression
DE60137414D1 (de) Zusammensetzungen zur stimulierung der regeneration und der wiederherstellung des nervensystems durch regulierung der arginase 1- und polyamin-synthese
Kati et al. Evaluation of dapoxetine treatment success in lifelong premature ejaculation patients with penile sympathetic skin response
Price et al. The use of background EEG activity to determine stimulus timing as a means of improving rTMS efficacy in the treatment of depression: a controlled comparison with standard techniques

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.